Publication:
Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

dc.contributor.authorRyan, Pablo
dc.contributor.authorValencia, Jorge
dc.contributor.authorSepulveda-Crespo, Daniel
dc.contributor.authorAmigot-Sánchez, Rafael
dc.contributor.authorCuevas, Guillermo
dc.contributor.authorLazarus, Jeffrey V
dc.contributor.authorPérez-García, Felipe
dc.contributor.authorMartinez, Isidoro
dc.contributor.authorResino, Salvador
dc.contributor.funderGilead Sciences (Spain)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderAbbVie
dc.contributor.funderAsociación Española para el Estudio del Hígado
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderUnión Europea. Comisión Europea. NextGenerationEU
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas)
dc.contributor.funderMadrid Positivo Association
dc.date.accessioned2025-06-10T10:59:36Z
dc.date.available2025-06-10T10:59:36Z
dc.date.issued2024-10-01
dc.description.abstractImportance: Hepatitis C virus (HCV) microelimination aims to detect and treat hidden infections, especially in at-risk groups, like people experiencing homelessness (PEH) with alcohol or drug use disorders. Point-of-care HCV RNA testing and peer support workers are crucial for identifying and preventing HCV infection among marginalized populations, contributing to overall elimination goals. Objective: To assess risk factors, prevalence, and trends of active HCV infection among PEH in Madrid, Spain (2019-2023). Design, setting, and participants: This cross-sectional study was conducted between 2019 and 2023 in PEH, defined as people who lacked a fixed, regular, and adequate night residence, screened on the street or in homeless shelters via mobile unit using rapid HCV antibody testing, followed by HCV-RNA testing in Madrid, Spain. Data were analyzed from January to June 2024. Main outcomes and measures: Active HCV infection among PEH was the main outcome. Risk factors analyzed included being born outside of Spain, alcohol misuse, lacking financial income, benzodiazepine use, injection drug use (IDU; including nonactive IDU and active IDU within the last year), opioid substitution therapy participation, and sexual behavior patterns. Data were analyzed using logistic regression. P values were adjusted for multiple testing using the false discovery rate (q-values). Results: A total of 4741 individuals were screened for HCV infection, of whom 2709 (mean [SD] age, 42.2 [12.7]; 1953 [72.2%] men) were PEH and included in analysis. A total of 363 PEH (13.4%) had test results positive for HCV antibodies, of whom 172 (47.4%) had test results positive for HCV-RNA, and 148 of these (91.9%) started HCV treatment. Overall, active HCV infection prevalence was 6.3%, and the main risk factors associated with active HCV infection included IDU, encompassing both nonactive IDU (adjusted odds ratio [aOR], 10.9; 95% CI, 6.1-19.4; q < .001) and active IDU in the last year (aOR, 27.0; 95% CI, 15.2-48.0; q < .001); a lack of financial income (aOR, 1.8; 95% CI, 1.1-2.9; q = .03); and alcohol misuse (aOR, 1.8; 95% CI, 1.3-2.6; q = .008). There was a significant decrease between 2019 and 2023 in active HCV infection prevalence across the entire population, from 7.2% to 3.4% (P = .04). Conclusions and relevance: In this cross-sectional study of PEH in Madrid, IDU, lack of income, and alcohol misuse were primary risk factors associated with HCV infection. The significant decline in HCV rates observed across all risk groups during the study period suggests preventive policies were effective in reducing HCV prevalence among the homeless population.
dc.description.peerreviewed
dc.description.sponsorshipThis work was funded by grants from Gilead Sciences (grant No. IN-ES-380-6205, IN-ES-987-5391, GLD19_0096 [to Dr Ryan] and GLD20_0144 [to Dr Resino]) and Instituto de Salud Carlos III (ISCIII; grant No. PI20CIII/00004 [to Dr Resino], PI23CIII/00018 [to Dr Sepúlveda-Crespo and Martínez], and PI19CIII/00009 [to Dr Martínez]). It also received funding from AbbVie, the Asociación Española para Estudio del Higado, and the Madrid Positivo Association. The study was also funded by the Consorcio Centro de Investigación Biomédica en Red (CB 2021), ISCIII, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU (grant No. CB21/13/00044 [to Dr Resino). Dr Sepúlveda-Crespo is a Miguel Servet researcher from ISCIII (grant No. CP23CIII/00004)
dc.format.number10
dc.format.pagee2438657
dc.format.volume7
dc.identifier.citationRyan P, Valencia J, Sepúlveda-Crespo D, Amigot-Sánchez R, Cuevas G, Lazarus JV, Pérez-García F, Martínez I, Resino S. Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain. JAMA Netw Open. 2024 Oct 1;7(10):e2438657.
dc.identifier.doi10.1001/jamanetworkopen.2024.38657
dc.identifier.e-issn2574-3805
dc.identifier.journalJAMA network open
dc.identifier.pubmedID39453657
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26726
dc.language.isoeng
dc.publisherJAMA Network
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CB21/13/00044
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CP23CIII/00004
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI20CIII/00004
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI23CIII/00018
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI19CIII/00009
dc.relation.publisherversionhttps://doi.org/10.1001/jamanetworkopen.2024.38657
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.repisalud.instituteIIS::IiSGM - Instituto de Investigación Sanitaria Gregorio Marañón (Madrid)
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshAdult
dc.subject.meshCross-Sectional Studies
dc.subject.meshFemale
dc.subject.meshHepacivirus
dc.subject.meshHepatitis C
dc.subject.meshHumans
dc.subject.meshIll-Housed Persons
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPrevalence
dc.subject.meshRisk Factors
dc.subject.meshSpain
dc.subject.meshSubstance Abuse, Intravenous
dc.titlePrevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication3ef39da6-a7d1-43fc-8309-3429a6ea9918
relation.isAuthorOfPublication5c47cc76-bd60-48c6-aebb-47c08dbef4ed
relation.isAuthorOfPublication91fafbb0-4d25-4be8-969e-5b9941af71ca
relation.isAuthorOfPublication89b17350-14e3-4dfd-b797-6ee6ca5363b8
relation.isAuthorOfPublication89b17350-14e3-4dfd-b797-6ee6ca5363b8
relation.isAuthorOfPublication.latestForDiscovery3ef39da6-a7d1-43fc-8309-3429a6ea9918
relation.isFunderOfPublicatione30731f7-32c2-43af-b658-fe28964bc958
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationffb8e2d3-a3e4-4345-ade9-736e37d36399
relation.isFunderOfPublicationd9ab2217-c797-4f04-aac0-470082905377
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication54f29c6e-1163-4239-8d1d-a0f297ca06e6
relation.isFunderOfPublication0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72
relation.isFunderOfPublication.latestForDiscoverye30731f7-32c2-43af-b658-fe28964bc958
relation.isPublisherOfPublicationc5120ba7-9188-4d84-bfbd-a0c87718b2d5
relation.isPublisherOfPublication.latestForDiscoveryc5120ba7-9188-4d84-bfbd-a0c87718b2d5

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
Prevalence_HCV_InfectionAmongPeople_2024.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary1_Prevalence_HCV_InfectionAmongPeople_2024.pdf
Size:
488.09 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary2_Prevalence_HCV_InfectionAmongPeople_2024.pdf
Size:
15.02 KB
Format:
Adobe Portable Document Format